Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
$1.60
+2.9%
$1.75
$1.03
$2.55
$11.97M77.73540,333 shs18,247 shs
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$0.33
-14.8%
$0.35
$0.25
$1.28
$17.03M1.19167,432 shs4.12 million shs
Marpai, Inc. stock logo
MRAI
Marpai
$1.33
+2.4%
$1.05
$0.40
$2.08
$19.83M4.7419,115 shs55,790 shs
Ontrak, Inc. stock logo
OTRK
Ontrak
$1.57
+0.6%
$1.53
$1.27
$5.53
$6.62M2.3452,471 shs24,293 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
-0.96%-9.36%-9.36%-20.92%+23.02%
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.00%0.00%0.00%-38.33%-69.05%
Marpai, Inc. stock logo
MRAI
Marpai
+12.07%-3.70%+28.71%+31.31%-34.01%
Ontrak, Inc. stock logo
OTRK
Ontrak
-0.64%-9.51%+8.33%-6.02%-61.19%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
3.3285 of 5 stars
3.55.00.00.00.73.31.3
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/AN/AN/AN/AN/AN/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/AN/AN/AN/A
Ontrak, Inc. stock logo
OTRK
Ontrak
2.5091 of 5 stars
3.55.00.00.01.00.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
3.00
Buy$18.001,028.53% Upside
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.00
N/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
0.00
N/AN/AN/A
Ontrak, Inc. stock logo
OTRK
Ontrak
3.00
Buy$45.002,766.24% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
$401K29.85N/AN/A$2.45 per share0.65
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$29.09M0.59N/AN/A$1.09 per share0.30
Marpai, Inc. stock logo
MRAI
Marpai
$34.87M0.57N/AN/A($1.72) per share-0.77
Ontrak, Inc. stock logo
OTRK
Ontrak
$10.85M0.61N/AN/A$5.56 per share0.28
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
-$14.41M-$1.47N/AN/AN/A-2,697.08%-98.49%-75.23%N/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
-$26.08MN/A0.00N/A-75.34%-7.96%-5.49%6/12/2025 (Estimated)
Marpai, Inc. stock logo
MRAI
Marpai
-$28.75M-$1.82N/AN/A-85.70%N/A-100.23%8/5/2025 (Estimated)
Ontrak, Inc. stock logo
OTRK
Ontrak
-$27.92M-$15.81N/AN/AN/A-237.77%-171.34%-113.42%8/6/2025 (Estimated)

Latest OTRK, MRAI, ENZ, and BRTX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/20/2025Q1 2025
Ontrak, Inc. stock logo
OTRK
Ontrak
-$1.24-$1.65-$0.41-$1.65N/A$2.02 million
5/14/2025Q1 2025
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
-$0.32-$0.56-$0.24-$0.64$0.38 million$0.03 million
4/14/2025Q4 2024
Ontrak, Inc. stock logo
OTRK
Ontrak
-$1.35-$9.54-$8.19-$9.54$3.08 million$3.08 million
3/27/2025Q4 2024
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
-$0.27-$0.20+$0.07-$0.20$0.48 million$0.50 million
3/17/2025Q2 2025
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/A-$0.02N/A-$0.03N/A$7.33 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
N/AN/AN/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$0.40123.08%N/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/A
Ontrak, Inc. stock logo
OTRK
Ontrak
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
N/A
2.95
2.95
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/A
2.55
2.28
Marpai, Inc. stock logo
MRAI
Marpai
N/A
0.82
0.82
Ontrak, Inc. stock logo
OTRK
Ontrak
0.19
1.17
1.17

Institutional Ownership

CompanyInstitutional Ownership
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
69.38%
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
36.90%
Marpai, Inc. stock logo
MRAI
Marpai
49.75%
Ontrak, Inc. stock logo
OTRK
Ontrak
12.95%

Insider Ownership

CompanyInsider Ownership
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
25.50%
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
11.40%
Marpai, Inc. stock logo
MRAI
Marpai
61.30%
Ontrak, Inc. stock logo
OTRK
Ontrak
1.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
BioRestorative Therapies, Inc. stock logo
BRTX
BioRestorative Therapies
77.51 million5.16 millionNot Optionable
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
52052.40 million46.29 millionOptionable
Marpai, Inc. stock logo
MRAI
Marpai
15014.90 million5.61 millionNo Data
Ontrak, Inc. stock logo
OTRK
Ontrak
2504.22 million4.14 millionNo Data

Recent News About These Companies

Ontrak (NASDAQ:OTRK) Shares Up 1.9% - Here's Why
Ontrak reports Q4 EPS ($9.29) vs. ($4.02) last year
Ontrak secures Medicaid provider designation in two new states
ONTRAK INC. DL -,0001 (HY10.DU)
Ontrak Inc (HY10.MU)
Ontrak Inc. (HY10.SG)

New MarketBeat Followers Over Time

Media Sentiment Over Time

BioRestorative Therapies stock logo

BioRestorative Therapies NASDAQ:BRTX

$1.60 +0.05 (+2.90%)
Closing price 03:55 PM Eastern
Extended Trading
$1.60 0.00 (0.00%)
As of 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.

Enzo Biochem stock logo

Enzo Biochem NYSE:ENZ

$0.32 -0.06 (-14.83%)
Closing price 04/17/2025
Extended Trading
$0.32 0.00 (0.00%)
As of 04/17/2025 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

Marpai stock logo

Marpai NASDAQ:MRAI

$1.33 +0.03 (+2.40%)
As of 01:14 PM Eastern

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

Ontrak stock logo

Ontrak NASDAQ:OTRK

$1.57 +0.01 (+0.64%)
Closing price 04:00 PM Eastern
Extended Trading
$1.60 +0.03 (+1.85%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.